Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
p-Anisic acid, also known as 4-methoxybenzoic acid or draconic acid, is an organic compound belonging to the class of methoxybenzoic acids. It is a white crystalline solid that is insoluble in water but highly soluble in alcohols and ether. Naturally found in anise and other plants, it can be synthesized by oxidation of anethole or p-methoxyacetophenone[5][7]. p-Anisic acid exhibits antiseptic properties and has been used as a preservative in cosmetics and food products[1][5][7]. It also demonstrates antioxidant, anti-inflammatory, anti-tumor, anti-diabetic, tyrosinase inhibitory (skin lightening), and potential antibacterial activities[1]. Its mechanism of action includes inhibition of phospholipase A2[2], which may contribute to its anti-inflammatory effects. The compound is primarily used as a chemical intermediate rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on p-anisic acid.